• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of multiple angiogenic signaling and development of cancer-specific gene therapy

Research Project

Project/Area Number 12671164
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

TANAKA Shinji  Kyushu University Hospital, Assistant, 医学部・附属病院, 助手 (30253420)

Co-Investigator(Kenkyū-buntansha) SHIMADA Mitsuo  Kyushu University Hospital, Lecturer, 医学部・附属病院, 講師 (10216070)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsAngiopoietin / Tie2 / hepatocellular carcinoma / angiogenesis / vascular endothelial cell / WISP / CCN / CCN / シグナル伝達
Research Abstract

We have previously reported that Angiopoietin (Ang), a ligand for Tie2 vascular endothelial-specific receptor tyrosine kinase, may play a role in the progression of human hepatocellular carcinoma (HCC) is generally characterized as a hypervascular tumor of rapid growth (J Clin Invest 1999) and matrix proteinase expression (Cancer Res 2001). However, the role of Tie2 receptor in hepatic oncogenesis is unknown. The Tie2 receptor protein was overexpressed in the neovascular endothelium of 31/39 (80%) human HCC tumors by immunohistochemical analysis with significant correlation to cell dedifferentiation and tumor size (p<0.05). In vitro expression of a dominant-negative construct, containing a soluble Tie2 ectodomain (sTie2), led to Ang protein interaction, inhibition of endogeneous Tie2 phosphorylation in vascular endothelial cells, and matrix metalloproteinase-9 (MMP-9) suppression. Tumorigenicity with neovascularization was suppressed by in vivo gene transfer and sTie2 expression in a m … More urine HCC model suggesting a possible role for Tie2 expression in the induction of HCC neovascularization, and disease progression (Hepatology (in press)). More important, inhibition of the Ang/Tie2 signal transduction cascade is a promising approach for tumor treatment.
Using targeted differential displays, we identified a novel variant of the CCN family member WISP1 (Wnt-induced secreted protein 1), named WISP1v, as overexpressed in scirrhous gastric carcinomas. Members of the emerging family of the CCN gene (for connective tissue growth factor, cysteine-rich 61, nephroblastoma overexpressed) encode cysteine-rich secreted proteins with roles in human fibrotic disorders and cancer angiogenesis. Predicted protein of the WISP1 v completely lacks a module of Von Willebrand type C that is thought to participate in protein complex formation. Ectopic expression revealed WISP1 v to be a secreted oncoprotein inducing a striking cellular transformation and rapid piling-up growth. It is noteworthy that WISP1 v transfectants enhanced the invasive phenotype of co-cultured gastric carcinoma cells, while wild-type WISP1 had no such potential. These findings suggest that CCN protein WISP1 v is involved in the aggressive progression of scirrhous gastric carcinoma. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (40 results)

All Other

All Publications (40 results)

  • [Publications] Tanaka S, et al.: "Expression and anti-tumor effects of TRAIL in human cholangiocarcinoma"Hepatology. 32(3). 523-527 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "Grb7 signal transduction protein mediates metastatic progression of esopahgeal carcinoma"Journal of Cellular Physiology. 183(3). 411-415 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "A dominant negative mutation of transforming growth factor-beta receptor type II in microsatellite stable oesophageal carcinoma"British Journal of Cancer. 82(9). 1557-1560 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma"Digestive Diseases and Sciences. 46(5). 1016-1021 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "A novel variant of WISP1 lacking a Von Willebrand type C module overexoressed in scirrhous gastric carcinoma"Oncogene. 20(39). 5525-5532 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma"Hepatology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR, Sugimachi K: "Expression and anti-tumor effects of TRAIL in human cholangiocarcinoma"Hepatology. 32(3). 523-527 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Sugimachi K, Kawaguchi H, Saeki H, Ohno S, Wands JR, Sugimachi K: "Grb7 signal transduction protein mediates metastatic progression of esopahgeal carcinoma"Journal of Cellular Physiology. 183(3). 411-415 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Mori M, Mafune K, Ohno S, Sugimachi K: "A dominant negative mutation of transforming growth factor-beta receptor type II in microsatellite stable oesophageal carcinoma"British Journal of Cancer. 82(9). 1557-1560 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Ueo H, Mafune K, Mori M, Wands JR, Sugimachi K: "A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma"Digestive Diseases and Sciences. 46(5). 1016-21 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, Shimada M, Maehara Y, Sugimachi K: "A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in cirrhous gastric carcinoma"Oncogene. 20(39). 5525-32 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Sugimachi K, Maehara Si, Shirabe K, Shimada M, Wands JR, Sugimachi K: "Oncogenic signal transduction and therapeutic strategy for hepatocel lular carcinoma"Surgery. 131(1 Pt 2). S142-7 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, Sugimachi K, Yamashita Yi, Ohga T, Shirabe K, Shimada M, Wands JR, Sugimachi K: "Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma"Hepatology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K: "p53 polymorphism in human papillomavirus-associated esophageal cancer"Cancer Research. 60(11). 2753-2755 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Shimada M, Rikimaru T, Sugimachi K, Hamatsu T, Yamashita Y, Aishima S, Taguchi K, Tanaka S, Shirabe K, Sugimachi K: "The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver"Journal of American College of Surgeons. 191(5). 531-7 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamashita Yi, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Sugimachi K: "Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model"Cancer Research. 61(3). 1005-1012 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Etoh T, Inoue H, Tanaka S, Bernard GF, Kitano S, Mori M: "Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases"Cancer Research. 61(5). 2145-2153 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugimachi K, Taguchi Ki, Aishima Si, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi: "Altered Expression of beta-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma"Modern Pathology. 14(9). 900-5 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugimachi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M: "The Role of Overexpression and Gene Amplification of Cyclin D1 in Intrahepatic Cholangiocarcinoma"Journal of Hepatology. 35(1). 74-79 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kinoshita J, Kitamura K, Kanashima A, Saeki H, Tanaka S, Sugimachi K: "Clinical Significance of Vascular Endothelial Growth Factor-C (VEGF-C) in Breast Cancer"Breast Cancer Research and Treatment. 66(2). 159-64 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Saeki H, Tanaka S, Tokunaga E, Kawaguchi H, Ikeda Y, Maehara Y, Sugimachi K: "Genetic alterations in human TCF-4 gene in sporadic gastrointestinal cancers with microsatellite instability in the Japanese"Oncology. 61(2). 156-61 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Shimada M, Rikimaru T, Hamatsu T, Yamashita Y, Terashi T, Taguchi K, Tanaka S, Shirabe K, Sugimachi K: "The role of macroscopic classification in nodular-type hepatocellular carcinoma"American Journal of Surgery. 182(2). 177-82 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Sugimachi K: "Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial"Archives of Surgery. 36(3). 328-33 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamashita Yi, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, Sugimachi K: "Bile Leakage After Hepatic Resection"Annals of Surgery. 233(1). 45-50 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Shimada M, Hashizume M, Maehara S, Tsujita E, Rikimaru T, Yamashita Y, Tanaka S, Adachi E, Sugimachi K: "Laparoscopic hepatectomy for hepatocellular carcinoma"Surgical Encoscopy. 15. 541-4 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K: "Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma"Journal of Hepatobiliary Pancreatic Surgery. 8(5). 410-6 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamashita Y, Shimada M, Tsujita E, Tanaka S, Ijima H, Nakazawa K, Sakiyama R, Fukuda J, Ueda T, Funatsu K, Sugimachi K: "Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver"Cell Transplantation. 10(8). 717-22 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamashita Yi, Shimada M, Tanaka S, Okamoto M, Miyazaki Ji, Sugimachi K: "Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma"Human Gene Therapy. 13(2). 275-86 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kinoshita J, Kitamura K, Tanaka S, Sugimachi K, Ishida M, Saeki K: "Clinical significance of PEA3 in human breast cancer"Surgery. 131(1 Pt 2). S222-5 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugimachi K, Tanaka S, Terashi T, Taguchi K, Shimada M, Sugimachi K: "The mechanisms of angiogenesis in hepatocellular carcinoma: Angiogenic switch during tumor progression"Surgery. 131(1 Pt 2). S135-41 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tanaka S, et al.: "A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma"Onceogene. 20(39). 5525-5532 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tanaka S, et al.: "A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma"Digestive Diseases and Sciences. 46(5). 1016-1021 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tanaka S, et al.: "Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma"Hepatology. (in press).

    • Related Report
      2001 Annual Research Report
  • [Publications] Tanaka S, et al.: "Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma"Surgery. 131(1 Pt 2). S142-S147 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tanaka S, et al.: "Expression and anti-tumor effects of TRAIL in human cholangiocarcinoma."Hepatology. 32(3). 523-527 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tanaka S, et al.: "Grb7 signal transduction protein mediates metastatic progression of esopahgeal carcinoma."Journal of Cellular Physiology. 183(3). 411-415 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tanaka S, et al.: "A dominant negative mutation of transforming growth factor-beta receptor type II in microsatellite stable oesophageal carcinoma."British Journal of Cancer. 82(9). 1557-1560 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tanaka S, et al.: "A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma."Digestive Diseases and Sciences. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] 田中真二 他: "癌転移に関する新しい食道癌分子標的のクローニング"日本消化器外科学会誌. 33(4). 529-532 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 田中真二: "APC/beta-カテニンシグナルを制御する新しいヒト食道癌frizzled遺伝子の発見"福岡医学雑誌. 91(3). 67-69 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi